Academic literature on the topic 'Heroin abuse Treatment Case studies'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Heroin abuse Treatment Case studies.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Heroin abuse Treatment Case studies"

1

Suardi, N. E., M. Preve, M. Godio, E. Bolla, R. A. Colombo, and R. Traber. "Misuse of pregabalin: Case series and literature review." European Psychiatry 33, S1 (March 2016): S312. http://dx.doi.org/10.1016/j.eurpsy.2016.01.1067.

Full text
Abstract:
IntroductionPregabalin is widely used in neurology, psychiatry and primary healthcare, and recently in literature different studies explain the possible misuse [1,2]. Pregabalin has shown greater potency in preclinical models of epilepsy, pain and anxiety, and may have potential in the treatment of cocaine addiction [3]. The purpose of this report is to review the clinical evidence for the potential of abuse and misuse of pregabalin. We propose ten different cases and literature review.MethodTen inpatients with misuse of pregabalin were assessed with: the SCID-P, Anamnestic Folio, HAM-A and DAST. We conducted a systematic review of the literature (PubMed, Embase, PsychInfo), using the terms “pregabalin”, “misuse”.ResultsAll our patients present: cocaine, alcohol and/heroin positive in drugs urine screening at admission; a significant high level of total anxiety at the HAM-A Tot (P < .001), and especially at the item 7 (P < .001); the misuse of pregabalin is made for sniffing; the predominant symptoms assessed were euphoria, psychomotor activation and sedation.Discussion and conclusionSchifano F et al., [1,2] suggest that pregabalin should carefully prescribe in patients with a possible previous history of drug abuse. Our result identifies a particular population the misuse pregabalin that are abuser of cocaine, alcohol and/or heroin. Further research is warranted to replicate our clinical and qualitative observations and, in general, quantitative studies in large samples followed up over time are needed. Methodological limitations, clinical implications and suggestions for future research directions are considered.Disclosure of interestThe authors have not supplied their declaration of competing interest.
APA, Harvard, Vancouver, ISO, and other styles
2

Bah, Yahya Muhammed. "Drug Abuse Among Street Children (Case Study: Commercial Vans Casual Apprentices at Car Parks)." Journal of Advance Research in Medical & Health Science (ISSN: 2208-2425) 4, no. 9 (September 30, 2018): 110–36. http://dx.doi.org/10.53555/nnmhs.v4i9.608.

Full text
Abstract:
In The Gambia like all nations, drug abuse is seen as a social and health problem that has many serious implications for the physical, social, psychological and intellectual development of the victims more especially, the children. Therefore, it continues to be a concern to families, community leaders, educators, social workers, health care professionals, academics, government and its development partners. Though there are some studies on drug abuse, there is none on children and drug abuse focusing on the street children the most vulnerable category. Street children are hypothesized to be more at risk of any epidemic including drug abuse. This study sought to determine the risk and prevalence of drug abuse among street children focusing on those in the car parks. The research was focused on six critical areas: level of knowledge of drug abuse, perception towards it, level of knowledge of the causes of it in the community and among street children, level of knowledge of negative impacts of it, level of knowledge of the preventive methods; and level of knowledge of the support services and treatments needed by victims. A structured questionnaire was used to collect the data from thirty five participants (i.e. one driver and six casual apprentices from each of the five car parks) were interviewed. The data was presented and analyzed using tables and percentage. The findings revealed among other things, that there is high level of awareness of drug abuse but the feelings towards it are mixed. Like other children, street children are abusing drugs mainly due to peer influence with the ultimate objective of getting high to relief stress, group recognition, desire to be trusted by peers, etc. Similarly, participants are highly aware of the negative impacts encompassing fighting, stealing, mental illness, etc. To finance the behavior, victims are engaged in all types of dangerous antisocial behavior including romantic ones exposing them to a range of diseases including STIs and HIV/AIDS. Marijuana is the most commonly abused drug. Though in the minority, some have started experimenting cocaine/coke, hashish; and heroin. While participants have good knowledge of the critical methods to fight drug abuse, the support services needed by victims, victims are mostly reluctant to seek the services not only because they are hard to find but fear societal stigmatization, exclusion and discrimination and professionals’ maltreatments.
APA, Harvard, Vancouver, ISO, and other styles
3

Agorastos, A., H. Zurhold, A. Petridou, and C. Haasen. "Addiction Services in Cyprus: Results of the EU Twinning Project Evaluation." European Psychiatry 24, S1 (January 2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)70539-5.

Full text
Abstract:
In April 2007 a European twinning project started between Cyprus and Germany, in order to assist Cyprus as a new Candidate Country in the implementation and harmonisation with the European Community's legislation, by evaluating the governmental drug services in Cyprus and their coordination and promoting the improvement and introduction of new drug treatment services. A field investigation studied parameters as population in need, treatment demand and coverage, as well as high risk patterns and their trend over the last years, showing an individual place of Cyprus in the international drug ranking, with the highest prevalence of cannabis and second highest on ecstasy abuse and one of the smallest in opiates and amphetamine consumption. Nevertheless heroin remains the primary drug of abuse in persons seeking treatment, although Cyprus was until 2008 the only country of the European Union without a substitution treatment. Furthermore this project studies in detail the current availability of the governmental drug facilities, their structure and coordination as well as the legal framework in which they operate, showing a still adapting drug care system, trying to keep up with the increasing special needs of the Cypriot population, but offering the presuppositions for an efficient and good functioning drug care system in the future.
APA, Harvard, Vancouver, ISO, and other styles
4

Gerra, Gilberto, Matteo Manfredini, Lorenzo Somaini, Icro Maremmani, Claudio Leonardi, and Claudia Donnini. "Sexual Dysfunction in Men Receiving Methadone Maintenance Treatment: Clinical History and Psychobiological Correlates." European Addiction Research 22, no. 3 (November 24, 2015): 163–75. http://dx.doi.org/10.1159/000441470.

Full text
Abstract:
Abstract: A variety of studies evidenced a relationship between drug use disorders and sexual dysfunction. In particular, heroin and opioid agonist medications to treat heroin dependence have been found to be associated with erectile dysfunction and reduced libido. Controversial findings also indicate the possibility of factors other than the pharmacological effects of opioid drugs concurring to sexual dysfunction. With the present study, we investigated the link between sexual dysfunction and long-term exposure to opioid receptor stimulation (heroin dependence, methadone maintenance treatment, methadone dosage), the potentially related hormonal changes reflecting hypothalamus-pituitary-gonadal axis function and prolactin (PRL) pituitary release, the role of adverse childhood experiences in the clinical history and the concomitant symptoms of comorbid mental health disorders in contributing to sexual problems. Forty male patients participating in a long-term methadone treatment program were included in the present study and compared with 40 healthy control subjects who never used drugs nor abused alcohol. All patients and controls were submitted to the Arizona Sexual Experiences Scale (ASEX), Child Experiences of Care and Abuse-Questionnaire (CECA-Q) and the Symptom Check List-90 Scale. A blood sample for testosterone and PRL assays was collected. Methadone dosages were recorded among heroin-dependent patients on maintenance treatment. Methadone patients scored significantly higher than controls on the 5-item rating ASEX scale, on CECA-Q and on Symptoms Check List 90 (SCL 90) scale. Testosterone plasma levels were significantly lower and PRL levels significantly higher in methadone patients with respect to the healthy control group. ASEX scores reflecting sexual dysfunction were directly and significantly correlated with CECA-Q neglect scores and SCL 90 psychiatric symptoms total score. The linear regression model, when applied only to addicted patients, showed that methadone dosages were not significantly correlated with sexual dysfunction scores except for ‘erectile dysfunction', for which an inverse association was evidenced. Testosterone values showed a significant inverse correlation with ASEX sexual dysfunction scores, CECA-Q neglect scores and psychiatric symptom at SCL 90 among methadone patients. PRL levels were directly and significantly correlated with sexual dysfunction scores, psychiatric symptoms at SCL 90 and CECA-Q neglect scores. Both testosterone and PRL did not correlate with methadone dosages. The present findings appear to support the view of childhood adversities and comorbid psychiatric symptoms contributing to sexual dysfunction and related hormonal changes among methadone patients, challenging the assumption that attributes sexual problems entirely to the direct pharmacological effects of opioid agonist medications.
APA, Harvard, Vancouver, ISO, and other styles
5

Luque, Bárbara, Victoriana García, and Carmen Tabernero. "Depression and Cognitive Impairment in a Spanish Sample of Psychoactive Substance Users Receiving Mental Health Care." Healthcare 10, no. 5 (May 11, 2022): 887. http://dx.doi.org/10.3390/healthcare10050887.

Full text
Abstract:
(1) Background: Numerous studies state that the abuse of psychoactive substances produces cognitive, emotional and behavioral disorders. The aim of this study is to analyze the relationship between the consumption of different psychoactive substances with cognitive performance and depression. (2) Methods: The sample was composed of 254 individuals (M = 41.81; SD = 10.74, from 18 to 69; 76% male) who received psychological treatment related to the use of substances. Participants were classified according to the main substance consumed: alcohol (42.9%), cannabis (20.5%), cocaine (15.4%), heroin (13%) and benzodiazepines (8.3%). The Montreal Cognitive Assessment and the Beck’s Depression Inventory were administrated. (3) The results indicated no statistically significant differences between levels of depression depending on the substance consumed. Regarding cognitive impairment, it was found that cocaine consumers have the worst level of cognitive impairment, while cannabis consumers have the best level of cognitive functioning. Finally, it was found that participants with severe depression have higher cognitive impairment than those who were diagnosed with moderate depression. (4) Conclusions: Given the high prevalence of depression and cognitive impairment with the abuse of psychoactive substances, early treatment is recommended to avoid a higher cognitive and emotional affectation.
APA, Harvard, Vancouver, ISO, and other styles
6

Dannatt, Lisa, Karen Jacqueline Cloete, Martin Kidd, and Lize Weich. "Frequency and correlates of comorbid psychiatric illness in patients with heroin use disorder admitted to Stikland Opioid Detoxification Unit, South Africa." South African Journal of Psychiatry 20, no. 3 (August 30, 2014): 6. http://dx.doi.org/10.4102/sajpsychiatry.v20i3.540.

Full text
Abstract:
<p><strong>Background</strong>. There is a lack of studies addressing the frequency and correlates of comorbidities among heroin users admitted for treatment in South Africa (SA). Objective. To assess the frequency and correlates of psychiatric comorbidity among patients with heroin use disorder admitted to the Opioid Detoxification Unit at Stikland Hospital in the Western Cape, SA.</p><p><strong>Method.</strong> Participants (<em>N</em>=141) were assessed for psychiatric illness (Mini International Neuropsychiatric Interview), comorbid substance use disorders (World Health Organization’s Alcohol Smoking Substance Involvement Screening Tool), and legal and social problems (Maudsley Addiction Profile). Demographic, personal, psychiatric and substance-use history, in addition to mental state examination on admission, were collected from the case notes.</p><p><strong>Results.</strong> The largest group of patients (<em>n</em>=56, 40%) had not been abstinent from heroin use since drug debut, and most had been arrested for drug-related activities (<em>n</em>=117, 83%) and had family conflicts related to use <em>(n</em>=135, 96%). Nicotine was the most common comorbid substance of dependence (<em>n</em>=137, 97%) and methamphetamine was the most common comorbid substance abused (<em>n</em>=73, 52%). The most common comorbid psychiatric illness was previous substance-induced psychosis (<em>n</em>=42, 30%) and current major depressive disorder (<em>n</em>=37, 26%). Current major depressive disorder was significantly associated with females (p=0.03), intravenous drug use (<em>p</em>=0.03), alcohol use (<em>p</em>=0.02), and a higher number of previous rehabilitation attempts (<em>p</em>=0.008).</p><p><strong>Conclusion.</strong> Patients with heroin use disorders present with high rates of psychiatric comorbidities, which underscores the need for substance treatment services with the capacity to diagnose and manage these comorbidities.</p>
APA, Harvard, Vancouver, ISO, and other styles
7

Duraes, Eliana F., Mohammed Asif, Ashley Modica, Giulia Sikorski, C. Scott Hultman, and Julie Caffrey. "863 Drug Addiction and Opioid Use in the Acute Burn Patient." Journal of Burn Care & Research 41, Supplement_1 (March 2020): S269—S270. http://dx.doi.org/10.1093/jbcr/iraa024.429.

Full text
Abstract:
Abstract Introduction In light of the opioid crisis, there is an increased interest in the acute pain management of patients with history of drug addiction. There is no consensus on pain management among different burn centers and the amount of narcotic prescription reportedly doubled over a seven year period according to Tully in 20191. Our aim was to study the association of previous drug addiction history and the treatment of acute burn patients with special interest on the daily morphine equivalent requirements. Methods A prospectively maintained database was queried to study acute burn patients admitted in a reference burn center from 2013 to 2018. Patients with a previous history of drug addiction (group 1) were compared to patients without it (group 2). Drug abuse was defined as patients with history of opioids abuse, heroin, cocaine, cannabis, inhalants, and alcoholism, specifically those with diagnostic codes on file. The expected mortality was calculated using the Premier® database. A p0.05 was considered significant. Results A total of 3046 patients were studied, 502 (16.5%) had previous history of drug abuse on file. Compared to group 2, group 1 had: more males - 343 (68.3%) vs 1456 (57.2%) p0.001; was younger - 45.7914.65 vs 52.0219.57 p0.001; required intubation at a higher rate - 100 (19.9%) vs 329 (12.9%) p0.001; longer intubation period - 2.4310.05 vs 1.377.71 p0.001; had a prolonged admission - 13.8728.82 vs 8.4816.58 p0.001; more surgeries - 1.213.30 vs 0.71.58 p=0.002, and a higher daily morphine milligram equivalent requirement - 148.34320.56 vs 56.0297.81 p0.001. The groups had similar expected mortality rates: 3.03% vs 3.56%p=0.483; which may be partly explained by the fact that the drug use history is not accounted for on the formula. No significant difference was seen on the burned area between the groups. Conclusions Drug addiction was associated with increased need for intubation and length of intubation, prolonged admission, increased surgery rate and a higher daily morphine equivalent usage. Further studies are necessary guide the treatment of the specific needs of these increasingly common burn patients subgroup and also to define the need of including the history of drug use on the expected mortality rate formula. Applicability of Research to Practice This study adds to the literature differences in the treatment of burn patients with history of drug addiction and highlights the need for specific protocols for improved care.
APA, Harvard, Vancouver, ISO, and other styles
8

Pacini, Matteo. "A case of drug abuse." Clinical Management Issues 2, no. 3 (September 15, 2008): 135–41. http://dx.doi.org/10.7175/cmi.v2i3.569.

Full text
Abstract:
Methadone maintenance is one of the well-known harm reduction strategies for public health intervention in heroin addiction. The significance of methadone treatment in preventing needle sharing, which in turn reduces the risk of HIV and HCV transmission among injectors, has been demonstrated. Methadone maintenance is also considered gathering site where heroin addicts can effectively acquire knowledge on harm reduction and drug rehabilitation. We report a case of a 34-years-old patient with a history of heroin abuse. Therapy with methadone was essential for an adequate management of the case. The article describe difficulties and complexities of heroin abuse management and the therapeutic role of methadone.
APA, Harvard, Vancouver, ISO, and other styles
9

Browne, Thom, Mark S. Gold, and David M. Martin. "The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19." Current Psychopharmacology 10, no. 2 (June 8, 2021): 138–54. http://dx.doi.org/10.2174/2211556010666210125124645.

Full text
Abstract:
Background: Globally, an alarming number of pharmaceutically active compounds are now routinely added to the street drugs of abuse, cocaine and heroin. In some cases, seventeen (17) or more potentially toxic compounds are found in a single street purchased bag or block of cocaine or heroin. Pharmacologically active compounds, impurities, or breakdown products from drug manufacturing and industrial chemicals (collectively referred to as toxic adulterants) are now found in street drugs. They include, but are not limited to: antipsychotics, antidepressants, anxiolytics, antihistamines, anthelmintics, anesthetics, antiinflammatorys, antipyretics, analgesics, antispasmodics, antiarrhythmics, antimalarials, veterinary medications, bronchodilators, expectorants, sedatives, muscle relaxers, natural/synthetic hallucinogens, decongestants, new psychoactive substances (NPS), industrial compounds, fungicides, and impurities in the manufacturing process. All can be found within a single street purchase of heroin or cocaine. Routine clinical or workplace drug testing will not detect all these toxic adulterants. Only specialty forensic tests, specifically ordered, will detect them. The synergistic effect on the human body of such an unprecedented combination of pharmacologically active compounds is unknown and potentially deadly. This is especially seen in daily substance users who are exposed to these combinations multiple times a day over an extended period of time. Individuals with substance use disorders (SUDs) have several co-occurring health problems that make them more susceptible to COVID-19, including compromised immune, pulmonary, cardiovascular, and respiratory systems. These problems are high-risk factors for the acquisition of COVID-19 infection and more serious complications from the virus, including hospitalization and death. Objective: The study aims to bring to the attention of public health officials, addiction medicine specialists, treatment officials, therapists, and the general public the alarming increase of dangerous toxic adulterants being added to street drugs and their potentially lethal synergistic effects. Also, it aims to provide insights into how these new formulations can have serious pathophysiological effects on individuals with Substance Abuse Disorders (SUDs) during the COVID-19 pandemic. Methods: The literature on street drug cutting agents, toxic adulterants, NPS, manufacturing byproducts, and other industrial compounds will be reviewed. Also, a review of the literature of pathophysiological effects, especially on SUD patients, in light of the COVID-19 pandemic will be presented. This is combined with international and USA studies that were carried out by the Colombo Plan that identified these new combinations of toxic adulterants in street drugs, using state-of-the-art field and forensic laboratory detection technologies. Results: The majority of street drugs, in some cases more than ninety-five percent, now have multiple toxic adulterants. It is rare that a street purchase of cocaine or heroin does not contain multiple toxic adulterants, cutting agents, NPS, manufacturing byproducts, or industrial chemicals. Conclusion: This dangerous new composition in world street drug supply is unprecedented and may be the undetected cause of many psychostimulant and opioid overdose deaths, as many toxic adulterants are not routinely tested in post-mortem or street drug seizure cases. In addition, several of these toxic adulterants create a catastrophic drop in white blood cells, causing neutropenia and making the substance users susceptible to a wide range of opportunistic infections, including COVID-19. This profound change in the world street drug supply has catastrophic implications for individuals with SUDs and our health care system, especially in the era of the COVID-19 pandemic.
APA, Harvard, Vancouver, ISO, and other styles
10

Molavi, N., A. Ghaderi, and HR Banafshe. "Determination of thallium in urine, blood, and hair in illicit opioid users in Iran." Human & Experimental Toxicology 39, no. 6 (February 3, 2020): 808–15. http://dx.doi.org/10.1177/0960327120903487.

Full text
Abstract:
Context: Heavy metals, including thallium and lead, are introduced to illicit drug users’ body as a result of using drugs such as cocaine and heroin. Objective: This study aimed to determine urine, blood, and hair thallium (Tl) concentrations in illicit opioid users along with the relevant clinical signs and symptoms consistent with thallotoxicosis and to compare them with the corresponding variables in the control non-opioid user group. Materials and Methods: This case–control study was conducted on 50 illicit opioid users who had abused opioids continuously for more than a year, referred to Amirie Drug Abuse Treatment Clinic in Kashan, Iran. The control group included 50 non-opioid users. Thallium concentrations in urine, blood, and hair were assessed in both groups ( n = 100) using electrothermal (graphite furnace) atomic absorption spectrometry (ET AAS, GF AAS). Results: In the studied group, the median (interquartile range) concentrations of thallium in urine, blood, and hair were 54.8 ± 79.9 μg/L, 14.5 ± 11.1 μg/L, and 5.4 ± 3.7 µg/g, respectively; these values were 4.8 ± 5.2 μg/L, 2.5 ± 2.4 μg/L, and 1.4 ± 1.1 µg/g, respectively, in the control group. There were significant differences in urine, blood, and hair thallium concentrations between the study group and the control group ( p < 0.001). There were significant correlations between duration of illicit opioid use and urine thallium concentrations ( r = 0.394, p = 0.005) and hair thallium concentrations ( r = 0.293, p = 0.039), but not with blood thallium concentrations ( r = 0.246, p = 0.085). Urine and blood thallium concentrations of illicit opioid users with clinical signs and symptoms consistent with thallotoxicosis of weakness ( p = 0.01), depression ( p = 0.03), and headache ( p = 0.03) were higher than users without these problems. Discussion and conclusion: The results of the study showed that thallium concentrations in urine, blood, and hair in illicit opioid users were significantly higher than the comparable concentrations in the control group. This can be due to the use of illicit opioids adulterated with thallium. Also, this study showed long-term illicit opioid use may lead to thallium exposure. In addition, cigarette smoking was associated with increased thallium exposure.
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Heroin abuse Treatment Case studies"

1

Dhand, Amar. "Peer learning among a group of heroin addicts in India : an ethnographic study." Thesis, University of Oxford, 2007. http://ora.ox.ac.uk/objects/uuid:0103cc06-7f34-432e-9499-5b06c8bf8757.

Full text
Abstract:
This is an ethnographic account of peer learning among a group of heroin 'addicts' in Delhi, India. This study responds to the limited attention given to 'naturalistic' or 'informal' peer learning patterns in the educational literature, and the lack of explicit exploration of the phenomenon among drug user populations. The study involved seven and a half months of fieldwork with the predominant use of participant observation and semi-structured interviews to generate data. Analysis was inductive and interpretive with the use of situated learning theory to 'tease out' patterns in the data. The participants were using and non-using addicts affiliated to SHARAN, a non-governmental organization (NGO) in the religious marketplace of Yamuna Bazaar. The group included approximately 300-500 members, 20 of whom were main informants. Analysis of the group organization revealed community-based and masculinity-based characteristics that enabled the group to manage stigma, promote 'positive' ideals, and co-construct nonhegemonic masculinities. Peer-based outreach was identified as a form of 'institutional' peer learning in which peer educators performed the roles of 'doctor', 'role model', and 'counsellor' during interactions with 'clients' that had the effect of disempowering clients in many cases. The practice of poetry in which peers created couplets in alternating exchanges was identified as one form of naturalistic peer learning that entailed processes of legitimate peripheral participation, meaning negotiation, and reflective learning. Street 'doctory' in which peers provided medical care in the form of procedures, illness discussions, and health consultancy was identified as another naturalistic peer learning pattern involving processes of legitimate peripheral participation, meaning negotiation, and learning through teaching. These findings suggest that naturalistic peer learning involved co-participatory processes that manifested in a diversity of everyday practices. It is recommended that engaging these processes and practices would be useful for interventions, while further research should explore such patterns in other contexts.
APA, Harvard, Vancouver, ISO, and other styles
2

Long, Amanda H. "Family dependency treatment courts case studies from Mecklenburg County's families in recovery Staying Together (First) Program /." View electronic thesis (PDF), 2009. http://dl.uncw.edu/etd/2009-2/longa/amandalong.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bunkell, Philippa. ""Stuck in limbo?" : an unregistered community organisation and treatment provision for substance abuse disorders : a case study in Michells Plain." Master's thesis, University of Cape Town, 2009. http://hdl.handle.net/11427/11866.

Full text
Abstract:
Includes abstract.
Includes bibliographical references (leaves 90-93).
This study is an examination of the structures and functions of an unregistered faith-based substance abuse treatment facility, the Recovery Home, run by a Church in Mitchells Plain, a historically disadvantaged community (HDC) in the Western Cape. In addition, the challenges that the Organisation faces in meeting the policy requirements set by the Department of Social Development (DoSD) to obtain accreditation by subscribing to evidence-based practices for an in-patient treatment centre are the main issues upon which this research is structured. Information was collected, through a qualitative case study approach. Methods used were the in-depth interview, observation, documentary research relevant to the registration process and a confidential journal exercise conducted with people being treated in the Recovery Home. A lack of resources and evidence-based practices prevents the Recovery Home from providing adequate treatment services. The Organisation is unable to register as it does not meet the minimum norms and standards set by the Department of Social Development (DoSD) to acquire accreditation. It has been suggested by the relevant authorities that the Organisation fits the description of a half way house. However, no official policy for the registration of such insitutions currently exists in South Africa. The Home's definition of the causes of substance use disorders (SUDs) is inadequate in that it is limited to environmental factors, most particularly the unfavourable socio-economic conditions that prevail in the community. The Organisation is providing a valuable service in a community where the state lacks effective intervention capacity. As it is unable to register, however, it remains limited in what it is able to achieve.
APA, Harvard, Vancouver, ISO, and other styles
4

O'Brien, Siobhan. "The ultimate alternative : a single case study understanding Jason's journey from addiction to self-recovery." Thesis, Lethbridge, Alta. : University of Lethbridge, Faculty of Health Sciences, c2012, 2012. http://hdl.handle.net/10133/3110.

Full text
Abstract:
The purpose of this research was to understand the lived experience of a person with a substance addiction that uses or has used alternative therapies for treatment. A single-case study approach was used to understand the lived experiences of Jason, a male in his mid-forties who is healing from a substance addiction. Through in-person interviewing and reading personal manuscripts written by the participant, data were collected. The data were analysed and interpreted using phenomenological and integral hermeneutics. Through the interpretations, it was clear that a major contributing factor to Jason’s drug use was the negative experiences he was carrying from his past. Once he was able to let go of the negativity and let his higher power guide him, his healing journey took a positive turn. Today, Jason lives in the moment and does not need drugs to heal the hurt he is feeling inside. He uses his ultimate alternative method, derived from within himself, to guide his journey in recovery.
viii, 155 leaves ; 29 cm
APA, Harvard, Vancouver, ISO, and other styles
5

Troyer, Laura Marie. "Perspectives on familial and social adjustment of children of alcoholics." CSUSB ScholarWorks, 1987. https://scholarworks.lib.csusb.edu/etd-project/398.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Brooks, Billy, S. Warfield, Robert P. Pack, Jeffrey A. Gray, Arsham Alamian, A. M. Hagaman, and Nicholas E. Hagemeier. "The ETSU Prescription Drug Abuse/Misuse Working Group: A Case Study for Inter-professional Research and Training in South Central Appalachia." Digital Commons @ East Tennessee State University, 2015. https://dc.etsu.edu/etsu-works/1383.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gomez-Gillard, Patricia Miriam. "Constructivist research project needs assessment of rural drug court clients: A case study." CSUSB ScholarWorks, 2002. https://scholarworks.lib.csusb.edu/etd-project/2110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nanchy, Nicole, and Michelle Sereese Green. "An exploratory study of barriers to psychotropic adherence from the client's perspective." CSUSB ScholarWorks, 2006. https://scholarworks.lib.csusb.edu/etd-project/3057.

Full text
Abstract:
The purpose of this study was to identify barriers to psychotropic adherence regimens in clients with Severe and Persistent Mental Illness (SPMI). Medication non-adherence perpetuates the cycle of psychotic episodes, which leads to rehospitalization, incarceration, and homelessness.
APA, Harvard, Vancouver, ISO, and other styles
9

Dunlap, Amy L. "Women with Addictions' Experience in Music Therapy." Ohio University / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=ohiou1483647124948226.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Miller, Barbara Elaine. "Women under the influence: Stressors which increase alcohol consumption." CSUSB ScholarWorks, 1994. https://scholarworks.lib.csusb.edu/etd-project/887.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Heroin abuse Treatment Case studies"

1

McCloskey, Deborah. Addiction--what's really going on?: Inside a heroin treatment program. Ann Arbor, MI: Loving Healing Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Friedman, Jennifer. Surviving heroin: Interviews with women in methadone clinics. Gainesville: University Press of Florida, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Donfrancesco, David. I ragazzi di Bianca: Esperienze e subculture del consumo di eroina. Acireale: Bonanno, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lowenthal, Rita. One-way ticket: Our son's addiction to heroin. New York: Beaufort Books, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Noller, Peter. Heroinszene: Selbst- und Fremddefinitionen einer Subkultur. Frankfurt [am Main]: Campus, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Noller, Peter. Junkie-Maschinen: Rebellion und Knechtschaft im Alltag von Heroinabhängigen. Wiesbaden: Deutscher Universitäts Verlag, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Clinton, Terry W., ed. The early drug courts: Case studies in judicial innovation. Thousand Oaks, Calif: Sage Publications, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

In my skin. Edinburgh: Canongate, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

In my skin: A memoir. New York: Arcade Pub., 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Perspectives on addiction: An integrative treatment model with clinical case studies. Thousand Oaks: SAGE Publications, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Heroin abuse Treatment Case studies"

1

Luke, Gemma. "Psychological treatment relating to intimate partner violence and domestic abuse in the family court context." In Further Case Studies in Forensic Psychology, 4–22. London: Routledge, 2022. http://dx.doi.org/10.4324/9781003213116-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

"Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis." In Drug Abuse: Prevention and Treatment, edited by Carlos Nordt and Rudolf Stohler, 263–67. Routledge, 2017. http://dx.doi.org/10.4324/9781315257341-17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ilaiwy, Amro, Jennifer Rowell, and Beatrice Hong. "Case 49: Insulin and Heroin: An Unfortunate Mix in an Overlooked Population." In Diabetes In Practice: Case Studies with Commentary, 202–4. American Diabetes Association, 2021. http://dx.doi.org/10.2337/9781580407663.49.

Full text
Abstract:
A 35-year-old woman was evaluated in the emergency department after she was found unconscious at home. Her medical history included type 1 diabetes diagnosed at the age of 10 years and managed with a Medtronic G670 insulin pump and Dexcom G6 continuous glucose monitor. She also had a known history of intravenous drug abuse.
APA, Harvard, Vancouver, ISO, and other styles
4

McIntosh, Belinda, and Michael T. Compton. "Response." In Case Studies in Clinical Psychological Science, 277–78. Oxford University Press, 2013. http://dx.doi.org/10.1093/med:psych/9780199733668.003.0036.

Full text
Abstract:
Dr. Bellack’s commentary highlights a number of important points in the assessment and treatment of patients with schizophrenia and related psychotic disorders. He emphasizes that, although many patients with schizophrenia receive pharmacotherapeutic and psychosocial treatments in keeping with the spirit of the recommendations, often the treatments being applied are not evidence-based. Dr. Bellack stresses that there are a number of manualized psychosocial treatments to guide clinicians wishing to provide evidence-based supported employment, social skills training, and substance abuse treatment. He also aptly cites that the bulk of mental health treatment for patients with schizophrenia occurs in community mental health settings that lack the resources to adequately provide these treatments....
APA, Harvard, Vancouver, ISO, and other styles
5

Reddy, Swathi M., Kristin Bolton, Cynthia Franklin, and Karla Gonzalez Suitt. "Substance Abuse and Recovery Through SFBT." In Solution-Focused Brief Therapy with Clients Managing Trauma, 118–34. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190678784.003.0008.

Full text
Abstract:
This chapter describes how SFBT has been used in the treatment of substance use and relies on the clinical literature to illustrate interventions. Specific ways to engage clients with substance use will be covered, including the questions to ask in order to promote change. In addition, this chapter will describe a case where SFBT has been used with a client with alcohol use disorder and explain how SFBT may be used in groups to treat substance use. Finally, this chapter will discuss the emerging outcome literature on SFBT with clients who have substance use including studies that assess substance use and trauma.
APA, Harvard, Vancouver, ISO, and other styles
6

"Randomized Trial of Oral Morphine for Chronic Noncancer Pain." In 50 Studies Every Anesthesiologist Should Know, edited by Anita Gupta, Elena N. Gutman, Michael E. Hochman, Anita Gupta, Elena N. Gutman, and Michael E. Hochman, 193–99. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190237691.003.0037.

Full text
Abstract:
This case focuses on opioids used for noncancer pain by asking the question: Do patients with chronic pain not due to cancer benefit from treatment with opioids? Among patients with non–cancer-related pain, sustained-release oral morphine led to a modest reduction in pain but no clear improvement in psychological or functional outcomes. Patients in the morphine group experienced an increased rate of gastrointestinal symptoms and dizziness. The study had important methodologic limitations, most notably that patients were only followed for 11 weeks. In addition, patients with a history of substance abuse were excluded, limiting the generalizability of the findings. Despite these limitations, this study represents one of the highest quality studies to evaluate opioids for chronic noncancer pain.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Heroin abuse Treatment Case studies"

1

Froes Carvalho, Vera, Miguel Carneiro, Sérgio Esteves, Sandra Torres, and Zita Gameiro. "Motivational interview for schizophrenia patients and alcohol abuse." In 22° Congreso de la Sociedad Española de Patología Dual (SEPD) 2020. SEPD, 2020. http://dx.doi.org/10.17579/sepd2020o038.

Full text
Abstract:
The co-occurrence of schizophrenia and alcohol use disorders often leads to poor treatment retention and adherence. There are very few reports of efficient approaches to treat alcohol abuse in patients with schizophrenia. The purpose of this work was to review the benefits of motivational interview (MI) for alcohol disorders in patients with schizophrenia, and if it can be use in default or if there are some adaptations for this specific population. The authors did a non-systematic review of the literature with the words “motivational interview”, “schizophrenia”, “alcohol”. A case report from 2017 shows a 42 years old man in which was valued the patient's narrative and opinions with support and understanding, that lead to a increase in motivation of abstinence. Reflective listening and summarizing were very important to help with the consciousness of the disease. A study from 2007 with 60 patients shows that they tolerate the shorter sessions (20–30 min) better than longer sessions, because of the difficult time focusing for an extended period of time. More sessions are advantageous because it takes some time for patients to learn how to respond. Other study from 2003 with 30 patients shows that subjects randomized to the MI intervention had a significant reduction in drinking days and an increase in abstinence rates when compared to subjects receiving educational treatment. A blind randomised controlled trial from 2010 with 327 patients shows that integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and substance misuse does reduce the amount of substance used for at least one year after completion of therapy. In conclusion there are evidence of the use of motivational interview in patients with schizophrenia. And the improve is bigger if there is an adaptation to this specific population. More studies are still needed in this aera.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Heroin abuse Treatment Case studies"

1

Madu, Laura, Jacqueline Sharp, and Bobby Bellflower. Efficacy of Integrating CBT for Mental Health Care into Substance Abuse Treatment in Patients with Comorbid Disorders of Substance Abuse and Mental Illness. University of Tennessee Health Science Center, April 2021. http://dx.doi.org/10.21007/con.dnp.2021.0004.

Full text
Abstract:
Abstract: Multiple studies have found that psychiatric disorders, like mood disorders and substance use disorders, are highly comorbid among adults with either disorder. Integrated treatment refers to the treatment of two or more conditions and the use of multiple therapies such as the combination of psychotherapy and pharmacotherapy. Integrated therapy for comorbidity per numerous studies has consistently been superior to the treatment of individual disorders separately. The purpose of this QI project was to identify the effectiveness of Cognitive Behavioral Therapy (CBT) instead of current treatment as usual for treating Substance Use Disorder (SUD) or mental health diagnosis independently. It is a retrospective chart review. The review examines CBT's efficacy for engaging individuals with co-occurring mood and substance u se disorders in treatment by enhancing adherence and preventing disengagement and relapse. Methods: Forty adults aged 26-55 with a DSM-IV diagnosis of a mood disorder of Major Depressive Disorder and/or anxiety and concurrent substance use disorder (at least weekly use in the past month). Participants received 12 sessions of individual integrated CBT treatment delivered with case management over a 12-week period. Results: The intervention was associated with significant improvements in mood disorder, substance use, and coping skills at 4, 8, and 12 weeks post-treatment. Conclusions: These results provide some evidence for the effectiveness of the integrated CBT intervention in individuals with co-occurring disorders. Of note, all psychotherapies are efficacious; however, it would be more advantageous to develop a standardized CBT that identifies variables that facilitate treatment outcomes specifically to comorbid disorders of substance use and mood disorders. It is concluded that there is potentially more to be gained from further studies using randomized controlled designs to determine its efficacy.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography